Update from GOV.UK for: MHRA approves zanidatamab (Ziihera) for the treatment of biliary tract cancer. Received in my inbox at 4:31 am Pac. time. First published (simultaneously) at 12:31pm, 19 February 2026 UK time per the official MHRA notice. This is how we'll first learn of our own approval.
Market Data 
Markets 
AI
